Christopher Kim insider trades
Open-market stock purchases and sales by Christopher Kim, Chairman and CMO at Apimeds Pharmaceuticals US, Inc, from SEC Form 4 filings since May 13, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 15, 2025 | APUS Apimeds Pharmaceuticals US, Inc | Bought (not open market) | — |
Companies traded
- APUS Apimeds Pharmaceuticals US, Inc: 2 buys, last Oct 15, 2025